SCHEMBL17629533

SCHEMBL17629533

CCOC(=O)CC(=O)N(Cc1ccc(C(F)(F)F)cc1)C1=C(C(=O)OC)CCOC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPM2 O94759 1/20 0.36
▸ PPARG P37231 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ EPHX2 P34913 1/20 0.35
▸ TLR2 O60603 1/20 0.35
▸ MAPK8 P45983 1/20 0.34
▸ MAPK10 P53779 1/20 0.34
▸ CETP P11597 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.33
▸ LSS P48449 1/20 0.33
▸ MAPT P10636 2/20 0.33
▸ PTGER4 P35408 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ CRHBP P24387 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ CRHR2 Q13324 1/20 0.33
▸ NR1H4 Q96RI1 1/20 0.33
▸ FPR2 P25090 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17629532 0.91 ALDH1A1 (0.37) TRPM2PPARGKDM4EALDH1A1EPHX2
SCHEMBL17629556 0.84 PPARG (0.35) TRPM2PPARGEPHX2CETPMAPT
SCHEMBL19251713 0.81 TLR2 (0.39) TRPM2PPARGKDM4EALDH1A1EPHX2
SCHEMBL3265220 0.78 LMNA (0.37) KDM4EALDH1A1NPSR1MAPTMEN1
SCHEMBL17629564 0.78 PPARG (0.35) TRPM2PPARGKDM4EALDH1A1EPHX2
SCHEMBL19251687 0.75 PPARG (0.38) TRPM2PPARGKDM4EALDH1A1EPHX2
SCHEMBL17629562 0.74 CACNA1F (0.36) TRPM2PPARGKDM4EALDH1A1EPHX2
SCHEMBL19251699 0.71 MAPT (0.39) TRPM2KDM4EALDH1A1CETPMAPT
SCHEMBL17629557 0.71 PTGER4 (0.44) KDM4EEPHX2MAPK8MAPK10LSS
SCHEMBL18025451 0.67 CCR2 (0.36) TRPM2PPARGKDM4EEPHX2CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197455-B1 INHIBITORS OF HIF PROLYL HYDROXYLASE MERCK SHARP & DOHME (US) 2020-12-30 — — EP disclosed
US-10000501-B2 Inhibitors of HIF prolyl hydroxylase MERCK SHARP & DOHME CORP. (US) 2018-06-19 — — US disclosed
US-20170240555-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE MERCK SHARP & DOHME CORP. (US) 2017-08-24 — — US disclosed
EP-3197455-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE Merck Sharp & Dohme Corp. (US) 2017-08-02 — — EP disclosed
WO-2016049097-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE MERCK SHARP & DOHME CORP. (US) 2016-03-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10000501-B2 Inhibitors of HIF prolyl hydroxylase HIF1AN, HIF1A, EGLN2 TRPM2 4739/4885PPARG 741/4885KDM4E 469/4885
US-20170240555-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE HIF1AN, HIF1A, EGLN2 TRPM2 4739/4885PPARG 741/4885KDM4E 469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback